Pharmabiz4h
CAGE Bio begins phase 2b clinical trial for CGB-500, a breakthrough topical JAK inhibitor for moderate to severe atopic dermatitis
CAGE Bio begins phase 2b clinical trial for CGB-500, a breakthrough topical JAK inhibitor for moderate to severe atopic dermatitis: San Carlos, California Saturday, January 11, 20 ...
Pharmabiz7h
SynCardia Systems gets CNIPA notification granting first patent covering company’s next-generation total artificial heart
SynCardia Systems gets CNIPA notification granting first patent covering company’s next-generation total artificial heart: Tucson, Arizona Saturday, January 11, 2025, 15:00 Hrs ...
Pharmabiz6h
Newron Pharma, Myung In Pharm ink license agreement to develop, manufacture & commercialize Newron’s evenamide in South Korea
Newron Pharma, Myung In Pharm ink license agreement to develop, manufacture & commercialize Newron’s evenamide in South Korea: Milan Saturday, January 11, 2025, 16:00 Hrs [IST] ...
Pharmabiz5h
FORE Biotherapeutics highlights pipeline achievements for its oncology programme; Provides objectives for 2025
FORE Biotherapeutics highlights pipeline achievements for its oncology programme; Provides objectives for 2025: Philadelphia Saturday, January 11, 2025, 17:00 Hrs [IST] FORE Bioth ...
Pharmabiz7d
Centre notifies amendments to Foreign Trade Policy 2023 to enhance stakeholder engagement
The Union ministry of commerce & industry has issued a notification introducing amendments to the Foreign Trade Policy (FTP) 2023, aimed at fostering enhanced stakeholder engagement. The notification, ...
Pharmabiz7d
GSK receives China NMPA approval for Nucala to treat adults with chronic rhinosinusitis with nasal polyps
GSK plc announced that the China National Medical Products Administration (NMPA) has approved Nucala (mepolizumab), a monoclonal antibody that targets interleukin-5 (IL-5), as an add-on therapy with ...
Pharmabiz7d
Artificial intelligence and machine learning transforming ICU decision-making: Experts
Artificial intelligence (AI) and machine learning (ML) are poised to redefine the landscape of critical care medicine, offering innovative solutions to the challenges faced in intensive care units ...
Pharmabiz7d
SIGA Technologies receives Japanese approval for Tepoxx for the treatment of orthopoxviruses
SIGA Technologies, a commercial stage pharmaceutical company, announced that its antiviral treatment Tepoxx (tecovirimat 200 mg capsules), marketed as Tpoxx in the United States, has received ...
Pharmabiz9d
Parliamentary panel asks DoP to take up issues related to schemes with state agencies
The Parliamentary panel that looked into the budget allocation for the Department of Pharmaceuticals (DoP) and related matters has recommended that the DoP should take up issues related to ...
Pharmabiz7d
Indian healthcare is at a transformative juncture: Dr Gowri Kulkarni
Indian healthcare is at a transformative juncture, with prevention taking centre stage in efforts to combat rising health challenges and chronic diseases. The year 2025 will see a stronger emphasis on ...
Pharmabiz7d
Telangana DCA conducts raids and seize counterfeit versions of Montek-LC tablets of Sun Pharma
Acting on a tip off, the drug control officials of the Telangana Drug Control Administration (DCA) conducted several raids at the premises of wholesale dealers in Hyderabad and seized spurious and ...
Pharmabiz8d
Innovent inks exclusive global license agreement with Roche to advance the development of IBI3009, a novel DLL3 targeted ADC candidate
Innovent Biologics, Inc. (Innovent), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and ...